Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Yazawa

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
The Journal of Dermatology|August 21, 2001
Successful treatment of a patient with lymphomatoid papulosis by methotrexateN Yazawa, S Kondo, M Kagaya, et al.
Clinical and Experimental Rheumatology|April 4, 2003
Clinical features of patients with systemic sclerosis accompanied by rheumatoid arthritisM Jinnin, H Ihn, K Yamane, et al.
The British Journal of Dermatology|February 17, 1999
Serum concentrations of vascular endothelial growth factor in collagen diseasesK Kikuchi, M Kubo, T Kadono, et al.
Rheumatology (Oxford, England)|February 22, 2003
Plasma plasmin-alpha2-plasmin inhibitor complex levels are increased in systemic sclerosis patients with pulmonary hypertensionM Jinnin, H Ihn, K Yamane, et al.
Rheumatology (Oxford, England)|July 11, 2000
Serum KL-6 in adult patients with polymyositis and dermatomyositisM Kubo, H Ihn, K Yamane, et al.
The Journal of Rheumatology|April 27, 2000
Serum levels of KL-6 as a useful marker for evaluating pulmonary fibrosis in patients with systemic sclerosisK Yamane, H Ihn, M Kubo, et al.
The British Journal of Dermatology|October 20, 2004
Rheumatoid factor isotypes and anti-agalactosyl IgG antibodies in systemic sclerosisY Mimura, H Ihn, M Jinnin, et al.
Arthritis and Rheumatism|June 16, 2001
Clinical significance of surfactant protein D as a serum marker for evaluating pulmonary fibrosis in patients with systemic sclerosisY Asano, H Ihn, K Yamane, et al.
The British Journal of Dermatology|August 22, 2000
Increased serum levels of soluble vascular cell adhesion molecule-1 and soluble E-selectin in patients with polymyositis/dermatomyositisM Kubo, H Ihn, K Yamane, et al.
Rheumatology (Oxford, England)|June 27, 2001
Antibodies to Th/To ribonucleoprotein in patients with localized sclerodermaK Yamane, H Ihn, M Kubo, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
The Journal of Dermatology|August 21, 2001
Successful treatment of a patient with lymphomatoid papulosis by methotrexateN Yazawa, S Kondo, M Kagaya, et al.
Clinical and Experimental Rheumatology|April 4, 2003
Clinical features of patients with systemic sclerosis accompanied by rheumatoid arthritisM Jinnin, H Ihn, K Yamane, et al.
The British Journal of Dermatology|February 17, 1999
Serum concentrations of vascular endothelial growth factor in collagen diseasesK Kikuchi, M Kubo, T Kadono, et al.
Rheumatology (Oxford, England)|February 22, 2003
Plasma plasmin-alpha2-plasmin inhibitor complex levels are increased in systemic sclerosis patients with pulmonary hypertensionM Jinnin, H Ihn, K Yamane, et al.
Rheumatology (Oxford, England)|July 11, 2000
Serum KL-6 in adult patients with polymyositis and dermatomyositisM Kubo, H Ihn, K Yamane, et al.
The Journal of Rheumatology|April 27, 2000
Serum levels of KL-6 as a useful marker for evaluating pulmonary fibrosis in patients with systemic sclerosisK Yamane, H Ihn, M Kubo, et al.
The British Journal of Dermatology|October 20, 2004
Rheumatoid factor isotypes and anti-agalactosyl IgG antibodies in systemic sclerosisY Mimura, H Ihn, M Jinnin, et al.
Arthritis and Rheumatism|June 16, 2001
Clinical significance of surfactant protein D as a serum marker for evaluating pulmonary fibrosis in patients with systemic sclerosisY Asano, H Ihn, K Yamane, et al.
The British Journal of Dermatology|August 22, 2000
Increased serum levels of soluble vascular cell adhesion molecule-1 and soluble E-selectin in patients with polymyositis/dermatomyositisM Kubo, H Ihn, K Yamane, et al.
Rheumatology (Oxford, England)|June 27, 2001
Antibodies to Th/To ribonucleoprotein in patients with localized sclerodermaK Yamane, H Ihn, M Kubo, et al.
Pageof 4